All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
AMYLYX PHARMACEUTICALS, INC. Last Reported: 9/30/2023 Stock Symbol: AMLX

Business Address

43 THORNDIKE STREET

CAMBRIDGE , MA US 02141

Mailing Address

43 THORNDIKE STREET

CAMBRIDGE , MA US 02141
Phone Number: 617-683-0917 / State Incorporated: DE / Fiscal Year End 12 /31

Balance Sheet

Date 6/30/2023 3/31/2023 12/31/2022 9/30/2022 6/30/2022 3/31/2022 12/31/2021 9/30/2021 3/31/2021 12/31/2020
Cash and Cash Equivalents $247,760,000.00 $114,563,000.00 $62,526,000.00 $107,734,000.00 $67,440,000.00 $110,403,000.00 $50,191,000.00 -- -- --
Accounts Receivable Net Current $33,473,000.00 $17,555,000.00 $15,306,000.00 $137,000.00 -- -- -- -- -- --
Inventory $24,858,000.00 $13,075,000.00 $9,769,000.00 $563,000.00 -- -- -- -- -- --
Prepaid Expenses and Other Current Assets $11,787,000.00 $12,749,000.00 $10,113,000.00 $8,336,000.00 $9,458,000.00 $10,283,000.00 $5,392,000.00 -- -- --
Total Current Assets $427,394,000.00 $389,053,000.00 $382,133,000.00 $172,199,000.00 $216,139,000.00 $265,488,000.00 $104,951,000.00 -- -- --
Property Plant and Equipement $2,637,000.00 $2,559,000.00 $2,611,000.00 $2,118,000.00 $1,857,000.00 $1,290,000.00 $474,000.00 -- -- --
Intangible Assets Net -- -- -- -- -- -- -- -- -- --
Goodwill -- -- -- -- -- -- -- -- -- --
Other Assets $466,000.00 $466,000.00 $466,000.00 $456,000.00 $456,000.00 $456,000.00 -- -- -- --
Total Assets $453,588,000.00 $407,958,000.00 $391,453,000.00 $181,443,000.00 $225,240,000.00 $274,438,000.00 $105,614,000.00 -- -- --
Accounts Payable $24,695,000.00 $10,770,000.00 $6,257,000.00 $7,052,000.00 $8,117,000.00 $10,045,000.00 $4,372,000.00 -- -- --
Accrued Liabilities $37,241,000.00 $38,753,000.00 -- -- -- -- -- -- -- --
Total Current Liabilities $67,223,000.00 $55,310,000.00 $50,846,000.00 $37,415,000.00 $32,451,000.00 $33,492,000.00 $17,431,000.00 -- -- --
Long Term Debt -- -- -- -- -- -- -- -- -- --
Additional Paid-in Capital $717,003,000.00 $705,263,000.00 $694,906,000.00 $456,263,000.00 $450,739,000.00 $444,784,000.00 $4,667,000.00 -- -- --
Accumulated Other Comprehensive Loss $-72,000.00 $25,000.00 $-86,000.00 $-725,000.00 $-196,000.00 $-151,000.00 $9,000.00 -- -- --
Accumulated Deficit $-330,573,000.00 $-352,647,000.00 $-354,220,000.00 $-311,500,000.00 $-257,760,000.00 $-203,700,000.00 $-155,845,000.00 -- -- --
Total Stockholders' Equity $386,365,000.00 $352,648,000.00 $340,607,000.00 $144,028,000.00 $192,789,000.00 $240,946,000.00 $-151,168,000.00 $-124,070,000.00 $-80,631,000.00 $-66,725,000.00
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- -- -- --
Total Liabilities and Equity $453,588,000.00 $407,958,000.00 $391,453,000.00 $181,443,000.00 $225,240,000.00 $274,438,000.00 $105,614,000.00 -- -- --

Statement of Operations

Date 6/30/2023 3/31/2023 12/31/2022 9/30/2022 6/30/2022 3/31/2022 12/31/2021 9/30/2021 3/31/2021 12/31/2020
Total Revenues -- -- $22,230,000.00 $345,000.00 -- -- -- $285,000.00 -- --
Cost of Revenues -- -- -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- -- -- --
Research and Development $53,236,000.00 $24,192,000.00 $93,450,000.00 $70,637,000.00 $24,259,000.00 $21,464,000.00 -- $12,853,000.00 $6,864,000.00 --
Selling, General, and Administrative $87,397,000.00 $44,006,000.00 $127,128,000.00 $86,284,000.00 -- -- -- $24,012,000.00 -- --
Total Operating Expenses -- -- -- -- $54,253,000.00 $47,814,000.00 -- -- $12,868,000.00 --
Loss from Operations $18,148,000.00 $-2,053,000.00 $-201,341,000.00 $-156,748,000.00 $-102,067,000.00 $-47,814,000.00 -- $-22,918,000.00 $-12,868,000.00 --
Loss Before Income Taxes $24,007,000.00 $1,403,000.00 $-197,601,000.00 $-53,881,000.00 $-101,595,000.00 $-47,702,000.00 -- $-23,142,000.00 $-14,523,000.00 --
Earnings Per Share Basic $0.35 $0.02 $-3.39 $-2.77 $-1.85 -- -- $-3.42 -- --
Weighted Average Shares Basic 66,976,871 66,717,271 58,495,587 58,533,226 58,275,903 -- -- 6,477,140 -- --
Earnings Per Share Diluted $0.34 $0.02 $-3.39 $-0.92 $-1.85 -- -- $-9.20 -- --
Weighted Average Shares Diluted 70,132,040 70,863,665 58,495,587 58,533,226 58,275,903 -- -- 6,477,140 -- --
Common Stock Shares Authorized 300,000,000 300,000,000 300,000,000 300,000,000 300,000,000 300,000,000 56,500,000 -- -- --
Common Stock Shares Outstanding 67,354,417 67,095,603 66,512,011 58,533,226 58,533,226 57,864,186 7,020,487 -- -- --
Common Stock Value $7,000.00 $7,000.00 $7,000.00 $6,000.00 $6,000.00 $6,000.00 $1,000.00 -- -- --
Common Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- -- --
Payments Of Dividends Common Stock -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Authorized 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 -- -- -- --
Preferred Stock Shares Outstanding -- -- -- -- -- -- -- -- -- --
Preferred Stock Value -- -- -- -- -- -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- -- --
Share Price -- -- $20.29 -- -- -- -- -- -- --
Copyright 2023 PursePoor.com